NVF-19006-95361

4 vaccinations 11 coded responses 50 check-ins 11 free-text entries 3 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 058 / VT
Registered: 2020-12-19

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-19
Registered in v-safe
2020-12-19
Dose 1 — Pfizer-BioNTech
2020-12-19
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2020-12-20
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Nausea

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2020-12-28
Health check-in — day 7, dose 1
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-01-02
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-09
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-01-11
Health check-in — day 0, dose 2
Feeling: Good · None

Adult check-in
2021-01-13
Survey response — days 1–6 daily, dose 2
MedDRA: Chills, Fatigue, Pain — Feeling: Fair · Site: Pain · Fatigue or tiredness

Free text: Chills, fatigue and body aches yesterday, which was the day after I received the injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain, Swelling · None

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Swelling, Itching · None

Adult check-in
2021-01-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Itching · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Itching · None

Adult check-in
2021-01-18
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-25
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-01
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-08
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-02-17
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-22
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-12
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-12
Survey response — 6 months, dose 2
MedDRA: Abortion spontaneous — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Pregnancy and spontaneous miscarriage at approximately 10 weeks gestational age

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-12
Report sent to call center — 6 months, dose 2
Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-13
Call 1 — Left Voicemail
2021-11-01
Dose 3 — Pfizer-BioNTech
2021-11-02
Survey response — days 1–6 daily, dose 3
MedDRA: Lymphadenopathy, Tenderness — Feeling: Fair · Site: Pain · Muscle or body aches, Nausea

Free text: tenderness and axillary swelling (suspect lymphadenopathy) ipsilateral to injection site

MedDRA releases: 2024-11 · check-in free text available
2021-11-03
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain, Oedema peripheral, Pallor, Rash erythematous, Tenderness — Feeling: Fair · Site: Pain · Muscle or body aches, Rash, not including the immediate area around the injection site

Free text: Increased pain, tenderness and swelling of left axilla (ipsilateral to injection site), yesterday evening developed transient erythematous, blanching reticular rash in the same area which has now receded

MedDRA releases: 2024-11 · check-in free text available
2021-11-04
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain, Oedema peripheral, Rash, Tenderness — Feeling: Good · Site: Pain

Free text: Swelling, pain, tenderness of left axilla (ipsilateral to injection site) are slowly improving. No recurrence of rash

MedDRA releases: 2024-11 · check-in free text available
2021-11-05
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain, Oedema peripheral, Tenderness — Feeling: Good

Free text: Left axillary (ipsilateral to injection site) swelling, pain and tenderness are still present but improving

MedDRA releases: 2024-11 · check-in free text available
2021-11-06
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain, Injection site reaction, Oedema peripheral, Tenderness — Feeling: Good

Free text: Left axillary (ipsilateral to injection site) swelling, pain and tenderness are almost resolved

MedDRA releases: 2024-11 · check-in free text available
2021-11-07
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-08
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-11-15
Health check-in — day 14, dose 3
Feeling: Good

Adult check-in
2021-11-22
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2021-11-29
Health check-in — day 28, dose 3
Feeling: Good

Adult check-in
2021-12-06
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-12-13
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-01-31
Survey response — 3 months, dose 3
MedDRA: COVID-19, Fatigue, Nasal congestion, Oropharyngeal pain, Rhinorrhoea — Feeling: Fair

Free text: COVID-19; rhinorrhea, nasal congestion, sore throat, fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-05-02
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2022-09-19
Dose 4 — Moderna
2022-09-19
Health check-in — day 0, dose 4
Feeling: Good · None

Adult check-in
2022-09-20
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea

Adult check-in
2022-09-21
Survey response — days 1–6 daily, dose 4
MedDRA: Tenderness — Feeling: Good · Site: Pain · Fatigue or tiredness

Free text: Mild axillary tenderness without obvious lymphadenopathy ipsilateral to injection site

MedDRA releases: 2024-11 · check-in free text available
2022-09-22
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-09-23
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-09-24
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-09-25
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Muscle or body aches, Fatigue or tiredness

Adult check-in
2022-09-26
Health check-in — day 7, dose 4
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-10-03
Health check-in — day 14, dose 4
Feeling: Fair

Adult check-in
2022-10-10
Health check-in — day 21, dose 4
Feeling: Fair

Adult check-in
2022-10-17
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-10-24
Survey response — day 35, dose 4
MedDRA: Caesarean section, Complication of delivery — Feeling: Fair · Get care from a doctor or other healthcare professional · Hospitalization

Free text: Gave birth on (b)(6)/22. Full-term, healthy baby by c-section for failure to progress

MedDRA releases: 2024-11 · check-in free text available
2022-10-24
Report sent to call center — day 35, dose 4
Get care from a doctor or other healthcare professional

Hospitalization · 1 call case(s)
2022-10-25
Call 1 — Left Voicemail
2022-10-31
Survey response — day 42, dose 4
MedDRA: Medical observation, Postpartum haemorrhage, Uterine dilation and curettage — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, Hospitalization

Free text: Symptoms: Postpartum hemorrhage 1 week after c-section · Healthcare visit (other): Overnight observation following suction dilation and curettage for postpartum hemorrhage which occurred 1 week after c-section

MedDRA releases: 2024-11 · check-in free text available
2022-10-31
Report sent to call center — day 42, dose 4
Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · Hospitalization · 1 call case(s)
2022-11-01
Call 2 — Left Voicemail
2022-11-01
Call 2 — Left Voicemail
2022-11-01
Call 1 — Left Voicemail
2022-12-21
Health check-in — 3 months, dose 4
Feeling: Good

Adult check-in
2023-03-22
Health check-in — 6 months, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-19	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech
3	2021-11-01	Pfizer-BioNTech	No
4	2022-09-19	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2021-07-12	Unsuccessful
2022-10-24	Unsuccessful
2022-10-31	Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-13

Systemic reaction (other): Chills, fatigue and body aches yesterday, which was the day after I received the injection

Release 9 — 6 months, dose 2

2021-07-12

Symptoms: Pregnancy and spontaneous miscarriage at approximately 10 weeks gestational age

Release 10 — days 1–6 daily, dose 3

2021-11-02

Systemic reaction (other): tenderness and axillary swelling (suspect lymphadenopathy) ipsilateral to injection site

2021-11-03

Systemic reaction (other): Increased pain, tenderness and swelling of left axilla (ipsilateral to injection site), yesterday evening developed transient erythematous, blanching reticular rash in the same area which has now receded

2021-11-04

Systemic reaction (other): Swelling, pain, tenderness of left axilla (ipsilateral to injection site) are slowly improving. No recurrence of rash

2021-11-05

Systemic reaction (other): Left axillary (ipsilateral to injection site) swelling, pain and tenderness are still present but improving

2021-11-06

Systemic reaction (other): Left axillary (ipsilateral to injection site) swelling, pain and tenderness are almost resolved

Release 11 — 3 months, dose 3

2022-01-31

Symptoms: COVID-19; rhinorrhea, nasal congestion, sore throat, fatigue

Release 12 — days 1–6 daily, dose 4

2022-09-21

Systemic reaction (other): Mild axillary tenderness without obvious lymphadenopathy ipsilateral to injection site

Release 12 — day 35, dose 4

2022-10-24

Symptoms: Gave birth on (b)(6)/22. Full-term, healthy baby by c-section for failure to progress

redacted (b)(6)

Release 12 — day 42, dose 4

2022-10-31

Symptoms: Postpartum hemorrhage 1 week after c-section

Healthcare visit (other): Overnight observation following suction dilation and curettage for postpartum hemorrhage which occurred 1 week after c-section

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Medical observation	·	·	✓
HCVO	Postpartum haemorrhage	·	·	✓
HCVO	Uterine dilation and curettage	·	·	✓
SD	Abortion spontaneous	✓	✓	✓
SD	Caesarean section	·	·	✓
SD	Complication of delivery	·	·	✓
SD	COVID-19	·	·	✓
SD	Fatigue	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Postpartum haemorrhage	·	·	✓
SD	Pregnancy	○	○	○
SD	Rhinorrhoea	·	·	✓
SRO	Axillary pain	·	·	✓
SRO	Chills	✓	✓	✓
SRO	Fatigue	✓	✓	✓
SRO	Injection site reaction	·	·	✓
SRO	Lymphadenopathy	·	·	✓
SRO	Oedema peripheral	·	·	✓
SRO	Pain	✓	✓	✓
SRO	Pallor	·	·	✓
SRO	Rash	·	·	✓
SRO	Rash erythematous	·	·	✓
SRO	Tenderness	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release